HK1014493A1 - Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases - Google Patents

Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases

Info

Publication number
HK1014493A1
HK1014493A1 HK98114792A HK98114792A HK1014493A1 HK 1014493 A1 HK1014493 A1 HK 1014493A1 HK 98114792 A HK98114792 A HK 98114792A HK 98114792 A HK98114792 A HK 98114792A HK 1014493 A1 HK1014493 A1 HK 1014493A1
Authority
HK
Hong Kong
Prior art keywords
preparation
cancerous diseases
methods
preparations containing
ivig
Prior art date
Application number
HK98114792A
Other languages
English (en)
Inventor
Yehuda Shoenfeld
Pnina Fishman
Original Assignee
Arp Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26907064&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1014493(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arp Biomed Ltd filed Critical Arp Biomed Ltd
Publication of HK1014493A1 publication Critical patent/HK1014493A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/54—F(ab')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98114792A 1994-03-14 1998-12-22 Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases HK1014493A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21236194A 1994-03-14 1994-03-14
US08/340,094 US5562902A (en) 1994-03-14 1994-11-15 Immunotherapeutic method of treating cancerous diseases by administration of intravenous immunoglobulin
PCT/US1995/002910 WO1995024927A1 (en) 1994-03-14 1995-03-09 Immunotherapeutic method of treating cancerous diseases by administration of gamma globulins

Publications (1)

Publication Number Publication Date
HK1014493A1 true HK1014493A1 (en) 1999-09-30

Family

ID=26907064

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98114792A HK1014493A1 (en) 1994-03-14 1998-12-22 Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases

Country Status (20)

Country Link
US (2) US5562902A (fi)
EP (1) EP0750514B1 (fi)
JP (2) JP4004062B2 (fi)
KR (1) KR100352583B1 (fi)
CN (1) CN1089007C (fi)
AT (1) ATE198711T1 (fi)
AU (1) AU700751B2 (fi)
BR (1) BR9507067A (fi)
CA (1) CA2184269A1 (fi)
DE (1) DE69519924T2 (fi)
DK (1) DK0750514T3 (fi)
ES (1) ES2155519T3 (fi)
FI (1) FI114011B (fi)
GR (1) GR3035758T3 (fi)
HK (1) HK1014493A1 (fi)
IL (1) IL112963A (fi)
NZ (1) NZ282659A (fi)
PT (1) PT750514E (fi)
TW (1) TW418091B (fi)
WO (1) WO1995024927A1 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070166313A1 (en) * 1994-03-14 2007-07-19 Yehuda Shoenfeld Administration of gamma globulins to treat cancer
US20080050390A1 (en) * 1994-03-14 2008-02-28 Yehuda Shoenfeld Administration of gamma globulins to treat metastatic melanoma
EP1076665A1 (en) 1998-05-07 2001-02-21 Research Corporation Technologies, Inc Oral administration of immunoglobulins for treating autoimmune hearing loss
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma
WO2001066124A2 (en) * 2000-03-10 2001-09-13 Medinnova Sf Composition for the treatment of heart failure
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
AU2002306251A1 (en) 2002-02-15 2003-09-04 Richard Brunner 7s immunoglobulin for treatment of choroidal neovascularisation_
US20080031903A1 (en) * 2006-07-27 2008-02-07 Andrea Gambotto Method of treating ocular infections
US20090053217A1 (en) * 2007-05-07 2009-02-26 Miri Blank Human anti-VEGF polyclonal antibodies and uses thereof
WO2010093606A1 (en) * 2009-02-11 2010-08-19 Martin Heath Bluth Reciprocal serum/plasma exchange for the treatment of cancer
CN114129722B (zh) * 2020-09-04 2024-04-05 中国医学科学院输血研究所 注射用人免疫球蛋白在制备预防或治疗辐照损伤的药物中的用途
CN114392351B (zh) * 2021-07-13 2024-04-05 中国医学科学院放射医学研究所 毛螺菌科细菌与注射用人免疫球蛋白的联合用药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699783A (en) * 1983-03-11 1987-10-13 Terman David S Products and methods for treatment of cancer
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
US4699784A (en) * 1986-02-25 1987-10-13 Center For Molecular Medicine & Immunology Tumoricidal methotrexate-antibody conjugate
TWI248819B (en) * 1999-09-27 2006-02-11 Arp Biomed Ltd Pharmaceutical composition containing IVIG for use in treating lymphoma

Also Published As

Publication number Publication date
EP0750514B1 (en) 2001-01-17
PT750514E (pt) 2001-06-29
DE69519924D1 (de) 2001-02-22
US5562902A (en) 1996-10-08
DE69519924T2 (de) 2001-08-23
IL112963A0 (en) 1995-06-29
FI963598A0 (fi) 1996-09-12
EP0750514A1 (en) 1997-01-02
KR100352583B1 (ko) 2002-12-26
AU1984895A (en) 1995-10-03
CA2184269A1 (en) 1995-09-21
FI963598A (fi) 1996-09-12
DK0750514T3 (da) 2001-05-21
WO1995024927A1 (en) 1995-09-21
FI114011B (fi) 2004-07-30
ATE198711T1 (de) 2001-02-15
JPH09512791A (ja) 1997-12-22
CN1148343A (zh) 1997-04-23
BR9507067A (pt) 1997-09-30
GR3035758T3 (en) 2001-07-31
JP4004062B2 (ja) 2007-11-07
ES2155519T3 (es) 2001-05-16
AU700751B2 (en) 1999-01-14
NZ282659A (en) 1998-06-26
IL112963A (en) 2000-02-17
JP2007119493A (ja) 2007-05-17
US5965130A (en) 1999-10-12
CN1089007C (zh) 2002-08-14
TW418091B (en) 2001-01-11

Similar Documents

Publication Publication Date Title
MY112405A (en) Method of tumer treatment.
GR3032511T3 (en) Combination with anti-hormonal compounds and binding molecules for the treatment of cancer.
HK1014493A1 (en) Immunotherapeutic preparations containing gamma globulins for treating cancerous diseases
GR3030867T3 (en) Guanidine derivatives useful in therapy
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
DE3789082D1 (de) Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors.
Lamb et al. Accelerated fractionation radiotherapy for advanced head and neck cancer
EP0944389A4 (en) PURIFIED COMPOSITIONS OF 10-PROPARGYL-10-DEAZAAMINOPTERIN AND METHODS OF USE THEREOF FOR THE TREATMENT OF TUMORS
GB8805792D0 (en) Medicaments
EP0511306A4 (en) Tumor killing effects of enterotoxins and related compounds
IL141550A0 (en) Methods and compositions for the prevention or treatment of cancer
HK1049608A1 (zh) 丙種球蛋白的投藥治療淋巴瘤
BR9808263A (pt) Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto.
WO2000006136A3 (en) Therapeutic combination of polyamine with an anticancer agent
MD798G2 (ro) Metoda de tratament a cancerului mamar
EP1234585A3 (en) Methods and compositions for the prevention or treatment of cancer
RU2093219C1 (ru) Способ лечения рака пищевода
DE59009724D1 (de) Verwendung von 7-oh-1,2-benzopyron zur herstellung eines arzneimittels zur behandlung von malignen tumoren beim menschen.
WO1991013633A1 (en) Improvements relating to immunoradiotherapy
DE59506911D1 (de) Verwendung von intravenös applizierbarem eisen zur therapie von tumorerkrankungen und/oder infektionskrankheiten
GB2233559A (en) Antibodies for use in antilymphocyte antibody therapy
RU97114158A (ru) Способ лечения злокачественных опухолей

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110309